0000000000154928

AUTHOR

Romano A

showing 45 related works from this author

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

2017

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, …

0301 basic medicine030204 cardiovascular system & hematologylaw.invention0302 clinical medicinec-reactive proteinRandomized controlled triallawCardiovascular Diseasemiddle ageddouble-blind methodantibodiesMyocardial infarctionhumansStrokeinterleukin-1betabiologyAntibodies MonoclonaldrugGeneral MedicineLipidAged; anti-inflammatory agents; antibodies; monoclonal; antibodies; monoclonal; humanized; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship; drug; double-blind method; female; humans; incidence; infections; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; strokestrokeAnti-Inflammatory AgentagedEditorialfemalemyocardial infarctionAtherosclerosiMonoclonalsecondary preventionHumanmedicine.drugmedicine.medical_specialtymonoclonalNeutropeniaAntibodies Monoclonal HumanizedInfectionsPlaceboaged; anti-inflammatory agents; antibodies monoclonal; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship drug; double-blind method; female; humans; incidence; infection; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; stroke; medicine (all)anti-inflammatory agentsdose-response relationshiplipids03 medical and health sciencesmaleInternal medicinemedicineneutropeniamedicine (all)Dose-Response Relationship Drugbusiness.industryAntiinflammatory Therapy Canakinumab for Atherosclerotic DiseaseC-reactive proteinmedicine.diseaseinfectioncardiovascular diseasesSurgeryCanakinumab030104 developmental biologyincidencebiology.proteinatherosclerosisbusinessNew England journal of medicine
researchProduct

Efficacia e tollerabilità dell'associazione caspofungin/amphotericina B liposomiale in pazienti con candidosi

2006

researchProduct

Considerazioni su un caso di schizosomiasi urinaria

2005

researchProduct

Diagnosis of congenital toxoplasmosis: pre-and post-natal evaluation in Sicilian (Italy) epidemiological area. Preliminary data.

2007

congenital toxoplasmosimanagement of congenital toxoplasmosisepidemiology of congenital toxoplasmosi
researchProduct

Infezioni invasive da Candida in gravi prematuri

2005

researchProduct

Morte cellulare programmata in oociti umani dopo ICSI

2005

researchProduct

Un caso di infezione da Geotrichum capitatum

2005

researchProduct

ThO to Th1 switch of CD4T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successfull therapy: lack of involvement o…

2005

researchProduct

Cuteneous leishmaniasis (CL) in western Sicily

2005

researchProduct

Epatite virale acuta da HEV a Palermo: descrizione di un caso

2005

researchProduct

Cystic hydatidosis: a rare case of spine localization.

2011

Echinococcus granulosus spinal echinococcosis.
researchProduct

Materno-fetal Toxoplasma gondii infection: critical review of available diagnotic methods

2008

researchProduct

Apoptosi in oociti umani non fecondati dopo ICSI

2004

researchProduct

Procalcitonin levels in plasma in oncohaematologic patients with an without bacterial infections

2004

BACKGROUND: The flogosis markers currently in use show both low sensitivity and specificity, particularly in neoplastic and degenerative diseases. Procalcitonin (PCT) is a pro-peptide of calcitonin produced mainly but not only in the C-cells of the thyroid glands and, as several studies show, PCT levels in plasma increase during infections. Bacterial infections are also the main cause of death in oncological patients. Furthermore, in patients with leukaemia in chemotherapy recovery, infections often induce relapses. The aim of the present study is to detect PCT levels in plasma in oncohaematologic patients with and without infections. METHODS: The study was carried out on 54 patients by a q…

researchProduct

UPREGULATION OF MIR-29A AND GENOMIC DNA HYPERMETHYLATION IN NORMAL KARYOTYPE AML SHOWING DNMT3A MUTATION UPREGOLAZIONE DEL MIR-29A E IPERMETILAZIONE …

2015

DNMT3A, a member of DNA methyltransferases, is mutated in approximately 22% of de novo normal karyotype acute myeloid leukemia (NK-AML) patients leading to adverse overall survival. The highly recurrent mutation in DNMT3A is a “gain of function-like” at codon R882. To indagate about miRNA signature in NK-AML R882-DNMT3A mutated we studied by qRT-PCR the expression of 384 known human miRNA in 9 selected de-novo AML DNMT3A mutated. We compared miRNA expression data with our previous results obtained in 31 AML DNMT3A wild type (WT) and we focused on a strong up-regulation of miR155, miR29a, miR196b and miR25. We consolidated this data in additional 24 new DNMT3A mutated AML and we confirmed th…

Settore BIO/18 - GeneticaAcute Myeloid Leukemia miRNA Genomewide DNA Methylation
researchProduct

Pulmonary tuberculosis in Italian children by age at presentation

2004

researchProduct

La granulisina nella malattia tubercolare: considerazioni su una casistica pediatrica.

2006

researchProduct

Infezione materno-fetale da toxoplasma gondii: analisi critica della diagnosi pre e post-natale

2005

researchProduct

INFEZIONE POLMONARE DA BLASTOSCHIZOMICES CAPITATUS

2005

Geotrichum capitatum, now known as Blastoschizomyces capitatus, can be responsible for several opportunistic infections (systemic infection or localized at lungs, liver, kidney, encephalitis or meningitis) in an immunocompromised host, especially in those patients affected by leukaemia or under immunosuppressive therapies. A 66-year-old woman with polimyosite under steroid and immunosuppressant therapy was hospitalized in ICU for an acute respiratory distress with moderate hypoxaemia and normocapnia. Pulmonary X-ray revealed a bilateral pneumonia. Hypoxaemia became severe 48 hours later and the patient underwent mechanical ventilation and empirical antibiotic therapy. Blood cultures, urine …

Immunocompromised HostBlastomyces isolation & purificationBlastomycosis diagnosiAntifungal Agents herapeutic useLung Diseases Fungal diagnosis
researchProduct

Follow-up post natale in nati da madre con infezione certa da Toxoplasma gondii considerazioni sul management prenatale.

2005

The clinical management of perinatal toxoplasmosis involves a gynaecologist during pregnancy and a neonatologist after delivery. Then, in the absence of a uniform approach, early evaluation of infected infants requires a thorough long-term follow-up also in asymptomatic children, who have to be observed for at least one year due to unpredictable sequelae in later life. We retrospectively analyzed pregnancy management of 54 women with certain infection from Toxoplasma gondii (TG) and prospectively enrolled their infants to compare prenatal management with postnatal clinical outcome. All mothers with seroconversion for TG infection were from the Palermo area and were retrospectively analyzed,…

pregnancy outcomeCongenital infectionToxoplasma gondiitreatment.
researchProduct

La spondilodiscite oggi: osservazioni su nove casi

2005

researchProduct

Un caso di sinusite da Aspergillus

2006

researchProduct

Infezione actinomicotica: considerazioni su due casi clinici

2006

researchProduct

Apoptosis in human unfertilized oocytes after ICSI

2005

researchProduct

Considerazioni su un caso di schistosomiasi urinaria.

2005

Urinary tract schistosomiasis is a parasitic disease caused by S. haematobium with a wide range of clinical manifestations related to the mucosal and submucosal granulomatous lesions of the bladder. It affects about 80 million people in Africa, Middle-East and India, while in Italy it is rarely seen among immigrants from endemic areas and returning travellers. The authors describe a case occurred in a 26 year old man, recently emigrated from a rural area of Ghana. He had the symptoms of a haemorrhagic cystitis. Cystoscopy and biopsy showed granulomatous lesions of bladder with calcified eggs. Microscopic examination of urine was positive for Schistosoma haematobium eggs. The therapy with Pr…

Bladder cancer Schistosomiasis Travelling disease
researchProduct

A novel ELISA system for detecting serum granulysin in tuberculosis patients

2006

researchProduct

Efficacia e tollerabilità di piperacillina/tazobactam in profilassi preoperatoria

2005

researchProduct

Diagnosis of congenital toxoplasmosis: pre e post natal evaluation in a sicilian (Italy) epidemiological area

2006

congenital toxoplasmosiepidemiological areapre e post natal evaluation
researchProduct

EMPIEMA PLEURICO MICOTICO: UNA ENTITà CLINICA EMERGENTE

2006

researchProduct

Follow-up diagnostico di bambini con sospetta toxoplasmosi connatale: valutazioni preliminari

2004

researchProduct

Mucormicosi cutanea primitiva: descrizione di un caso clinico

2005

researchProduct

Il significato della proteina C reattiva in cardiochirurgia nella diagnosi delle infezioni post-operatorie

2006

researchProduct

Toxoplasmosi: il western blot nella diagnosi dell'infezione materno-fetale. Dati preliminari

2006

Toxoplasmosidiagnosi 'infezione materno-fetalewestern blot
researchProduct

Hormonal, auxological and clinical follow-up in children with connatal HIV infection: personal records

2006

Auxological and endocrinological complications frequently occur in children with connatal HIV infection. These complications seem to be related both to the infection itself and the antiretroviral therapy. Many children consequently show height-weight and pubertal retardation without any evidence of hormonal deficit. We studied 10 children with connatal HIV infection who were enrolled in this analysis and followed up for 7 years in order to evaluate their height-weight growth, pubertal maturation, bone age progression and hormonal pattern [basal Growth hormone (GH) and GH after Clonidine or Insulin stimulation, Insulin-like Growth Factor 1 (IGF-1), Insulin-like Growth Factor Binding Protein …

MaleHIV hormonal follow-up auxological follow-up clinical follow-upSettore MED/17 - Malattie InfettiveBody WeightInfant NewbornInfantHIV InfectionsChild DevelopmentSettore MED/38 - Pediatria Generale E SpecialisticaChild PreschoolBody SizeHumansFemaleLongitudinal StudiesChildFollow-Up Studies
researchProduct

TBC, LUE e AIDS in immigrati extracomunitari. Considerazioni su tre casi

2006

researchProduct

Piperacillina/tazobactam in terapia empirica

2006

researchProduct

r-lh administration in multiple follicular stimolation for ivf: effects of apoptosis in cumulus cells, oocytes quality and clinical outcome

2005

researchProduct

Endocardite non brucellare

2005

researchProduct

Magnetic resonance and computed tomography findings in childhood central nervous system tuberculosis

2007

researchProduct

Utilizzo delle tre classi di antifungini per la terapia empirica in un reparto di terapia intensiva

2006

researchProduct

[Epidemiology of paediatric tuberculosis today].

2003

Tuberculosis (TB) kills 2 million people each year in the world, of which 250,000 are children. In Italy, paediatric TB is 3.5% of total cases with a steady trend in the last ten years. Childhood tuberculosis remains a disease of great concern because its occurrence always indicates recent transmission and is a pivotal indicator of effectiveness of TB control efforts. The epidemiological study, including DNA fingerprinting, of 71 children affected by TB - 62 pulmonary, 9 meningitis, 2 renal-shows that the source case is frequently a parent or household member. Sensitivity to anti-tubercular drugs was tested for 18/20 isolates obtained from the children and 21/44 isolates obtained from infec…

EpidemiologyTuberculosiChildhood
researchProduct

Valutazione della tollerabilità del linezolid in terapia a lungo termine

2005

researchProduct

Evoluzione del quadro neurostrumentale in tre bambini con infezione congenita da toxoplasma gondii (TG):follow-up gravidico e post natale

2004

researchProduct

Infezione primaria da Toxoplasma gondii in gravidanza: considerazioni su un campione di 58 coppie madre-bambino.

2004

researchProduct

Meningite tubercolare: valutazione dell'efficacia delle tecniche diagnostiche in età pediatrica.

2005

researchProduct